🟢 Humacyte is trading 5% up today amid a sector-driven biotech rebound

Humacyte is trading at $0.60 (+5.15%) as biotech trading rebounds after recent weakness.

• It is rebounding on September 2, 2026, after closing at $0.57 following three consecutive declining sessions.
• No new company-specific announcement dated September 2 was identified; the latest official release was August 24 regarding its planned November supplemental BLA filing.
• The move appears primarily sector-driven rather than a confirmed Humacyte catalyst.